> top > docs > PMC:2222968 > spans > 159-1494 > annotations

PMC:2222968 / 159-1494 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T121 0-13 NN denotes Transcription
T122 14-21 NN denotes factors
T123 22-25 VB denotes act
T124 26-28 IN denotes in
T125 29-36 NN denotes concert
T126 37-39 TO denotes to
T127 40-46 VB denotes induce
T128 47-54 NN denotes lineage
T129 55-65 NN denotes commitment
T130 66-73 IN denotes towards
T131 74-77 NN denotes Th1
T132 77-78 -COMMA- denotes ,
T133 79-82 NN denotes Th2
T134 82-83 -COMMA- denotes ,
T135 84-86 CC denotes or
T136 87-88 NN denotes T
T137 89-99 JJ denotes regulatory
T138 100-101 -LRB- denotes (
T139 101-105 NN denotes Treg
T140 105-106 -RRB- denotes )
T141 107-112 NN denotes cells
T142 112-113 -COMMA- denotes ,
T143 114-117 CC denotes and
T144 118-123 PRP-DOLLAR- denotes their
T145 124-142 JJ denotes counter-regulatory
T146 143-153 NN denotes mechanisms
T147 154-158 VB denotes were
T148 159-164 VB denotes shown
T149 165-167 TO denotes to
T150 168-170 VB denotes be
T151 171-179 JJ denotes critical
T152 180-183 IN denotes for
T153 184-196 NN denotes polarization
T154 197-204 IN denotes between
T155 205-208 NN denotes Th1
T156 209-212 CC denotes and
T157 213-216 NN denotes Th2
T158 217-227 NN denotes phenotypes
T159 229-234 NN denotes FOXP3
T160 235-237 VB denotes is
T161 238-240 DT denotes an
T162 241-250 JJ denotes essential
T163 251-264 NN denotes transcription
T164 265-271 NN denotes factor
T165 272-275 IN denotes for
T166 276-283 JJ denotes natural
T167 283-284 -COMMA- denotes ,
T168 285-299 JJ denotes thymus-derived
T169 300-301 -LRB- denotes (
T170 301-306 NN denotes nTreg
T171 306-307 -RRB- denotes )
T172 308-311 CC denotes and
T173 312-321 JJ denotes inducible
T174 322-326 NN denotes Treg
T175 327-328 -LRB- denotes (
T176 328-333 NN denotes iTreg
T177 333-334 -RRB- denotes )
T178 335-345 NN denotes commitment
T179 345-346 -COLON- denotes ;
T180 347-354 RB denotes however
T181 354-355 -COMMA- denotes ,
T182 356-359 DT denotes the
T183 360-370 NN denotes mechanisms
T184 371-381 VB denotes regulating
T185 382-385 PRP-DOLLAR- denotes its
T186 386-396 NN denotes expression
T187 397-400 VB denotes are
T188 401-403 RB denotes as
T189 404-407 RB denotes yet
T190 408-415 JJ denotes unknown
T191 417-419 PRP denotes We
T192 420-428 VB denotes describe
T193 429-430 DT denotes a
T194 431-440 NN denotes mechanism
T195 441-452 VB denotes controlling
T196 453-458 NN denotes iTreg
T197 459-471 NN denotes polarization
T198 471-472 -COMMA- denotes ,
T199 473-478 WDT denotes which
T200 479-481 VB denotes is
T201 482-491 VB denotes overruled
T202 492-494 IN denotes by
T203 495-498 DT denotes the
T204 499-502 NN denotes Th2
T205 503-518 NN denotes differentiation
T206 519-526 NN denotes pathway
T207 528-530 PRP denotes We
T208 531-543 VB denotes demonstrated
T209 544-548 IN denotes that
T210 549-560 NN denotes interleukin
T211 561-562 CD denotes 4
T212 563-564 -LRB- denotes (
T213 564-568 NN denotes IL-4
T214 568-569 -RRB- denotes )
T215 570-577 JJ denotes present
T216 578-580 IN denotes at
T217 581-584 DT denotes the
T218 585-589 NN denotes time
T219 590-592 IN denotes of
T220 593-594 NN denotes T
T221 595-599 NN denotes cell
T222 600-607 NN denotes priming
T223 608-616 VB denotes inhibits
T224 617-622 NN denotes FOXP3
T225 624-628 DT denotes This
T226 629-639 JJ denotes inhibitory
T227 640-649 NN denotes mechanism
T228 650-653 VB denotes was
T229 654-658 RB denotes also
T230 659-668 VB denotes confirmed
T231 669-671 IN denotes in
T232 672-675 NN denotes Th2
T233 676-681 NN denotes cells
T234 682-685 CC denotes and
T235 686-688 IN denotes in
T236 689-690 NN denotes T
T237 691-696 NN denotes cells
T238 697-699 IN denotes of
T239 700-710 JJ denotes transgenic
T240 711-715 NN denotes mice
T241 716-730 VB denotes overexpressing
T242 731-737 NN denotes GATA-3
T243 738-740 IN denotes in
T244 741-742 NN denotes T
T245 743-748 NN denotes cells
T246 748-749 -COMMA- denotes ,
T247 750-755 WDT denotes which
T248 756-759 VB denotes are
T249 760-765 VB denotes shown
T250 766-768 TO denotes to
T251 769-771 VB denotes be
T252 772-781 JJ denotes deficient
T253 782-784 IN denotes in
T254 785-797 VB denotes transforming
T255 798-804 NN denotes growth
T256 805-811 NN denotes factor
T257 812-813 -LRB- denotes (
T258 813-816 NN denotes TGF
T259 816-817 -RRB- denotes )
T260 817-828 JJ denotes -β–mediated
T261 829-834 NN denotes FOXP3
T262 835-844 NN denotes induction
T263 846-850 DT denotes This
T264 851-861 NN denotes inhibition
T265 862-864 VB denotes is
T266 865-873 VB denotes mediated
T267 874-876 IN denotes by
T268 877-883 JJ denotes direct
T269 884-891 NN denotes binding
T270 892-894 IN denotes of
T271 895-900 NN denotes GATA3
T272 901-903 TO denotes to
T273 904-907 DT denotes the
T274 908-913 NN denotes FOXP3
T275 914-922 NN denotes promoter
T276 922-923 -COMMA- denotes ,
T277 924-929 WDT denotes which
T278 930-939 VB denotes represses
T279 940-943 PRP-DOLLAR- denotes its
T280 944-959 NN denotes transactivation
T281 960-967 NN denotes process
T282 969-978 RB denotes Therefore
T283 978-979 -COMMA- denotes ,
T284 980-984 DT denotes this
T285 985-990 NN denotes study
T286 991-999 VB denotes provides
T287 1000-1001 DT denotes a
T288 1002-1005 JJ denotes new
T289 1006-1019 NN denotes understanding
T290 1020-1022 IN denotes of
T291 1023-1032 NN denotes tolerance
T292 1033-1044 NN denotes development
T293 1044-1045 -COMMA- denotes ,
T294 1046-1056 VB denotes controlled
T295 1057-1059 IN denotes by
T296 1060-1061 DT denotes a
T297 1062-1066 NN denotes type
T298 1067-1068 CD denotes 2
T299 1069-1075 JJ denotes immune
T300 1076-1084 NN denotes response
T301 1086-1090 NN denotes IL-4
T302 1091-1100 NN denotes treatment
T303 1101-1103 IN denotes in
T304 1104-1108 NN denotes mice
T305 1109-1116 VB denotes reduces
T306 1117-1122 NN denotes iTreg
T307 1123-1127 NN denotes cell
T308 1128-1137 NN denotes frequency
T309 1137-1138 -COMMA- denotes ,
T310 1139-1151 VB denotes highlighting
T311 1152-1156 IN denotes that
T312 1157-1168 JJ denotes therapeutic
T313 1169-1179 NN denotes approaches
T314 1180-1184 WDT denotes that
T315 1185-1191 VB denotes target
T316 1192-1196 NN denotes IL-4
T317 1197-1199 CC denotes or
T318 1200-1205 NN denotes GATA3
T319 1206-1211 MD denotes might
T320 1212-1219 VB denotes provide
T321 1220-1223 JJ denotes new
T322 1224-1234 JJ denotes preventive
T323 1235-1245 NN denotes strategies
T324 1246-1258 VB denotes facilitating
T325 1259-1268 NN denotes tolerance
T326 1269-1278 NN denotes induction
T327 1279-1291 RB denotes particularly
T328 1292-1294 IN denotes in
T329 1295-1307 JJ denotes Th2-mediated
T330 1308-1316 NN denotes diseases
T331 1316-1317 -COMMA- denotes ,
T332 1318-1322 JJ denotes such
T333 1323-1325 IN denotes as
T334 1326-1333 NN denotes allergy
R57 T122 T121 arg1Of factors,Transcription
R58 T122 T123 arg1Of factors,act
R59 T122 T127 arg1Of factors,induce
R60 T123 T124 arg1Of act,in
R61 T123 T126 modOf act,to
R62 T123 T143 arg1Of act,and
R63 T125 T124 arg2Of concert,in
R64 T127 T126 arg1Of induce,to
R65 T129 T127 arg2Of commitment,induce
R66 T129 T128 arg1Of commitment,lineage
R67 T129 T130 arg1Of commitment,towards
R68 T131 T132 arg1Of Th1,","
R69 T132 T135 arg1Of ",",or
R70 T133 T132 arg2Of Th2,","
R71 T135 T134 arg1Of or,","
R72 T136 T135 arg2Of T,or
R73 T139 T138 arg2Of Treg,(
R74 T140 T138 arg3Of ),(
R75 T141 T130 arg2Of cells,towards
R76 T141 T131 arg1Of cells,Th1
R77 T141 T133 arg1Of cells,Th2
R78 T141 T136 arg1Of cells,T
R79 T141 T137 arg1Of cells,regulatory
R80 T141 T138 arg1Of cells,(
R81 T143 T142 arg1Of and,","
R82 T146 T144 arg1Of mechanisms,their
R83 T146 T145 arg1Of mechanisms,counter-regulatory
R84 T146 T147 arg1Of mechanisms,were
R85 T146 T148 arg2Of mechanisms,shown
R86 T146 T150 arg1Of mechanisms,be
R87 T146 T151 arg1Of mechanisms,critical
R88 T148 T143 arg2Of shown,and
R89 T148 T147 arg2Of shown,were
R90 T150 T148 arg3Of be,shown
R91 T150 T149 arg1Of be,to
R92 T151 T150 arg2Of critical,be
R93 T151 T152 arg1Of critical,for
R94 T153 T152 arg2Of polarization,for
R95 T153 T154 arg1Of polarization,between
R96 T155 T156 arg1Of Th1,and
R97 T157 T156 arg2Of Th2,and
R98 T158 T154 arg2Of phenotypes,between
R99 T158 T155 arg1Of phenotypes,Th1
R100 T158 T157 arg1Of phenotypes,Th2
R101 T159 T160 arg1Of FOXP3,is
R102 T160 T179 arg1Of is,;
R103 T164 T160 arg2Of factor,is
R104 T164 T161 arg1Of factor,an
R105 T164 T162 arg1Of factor,essential
R106 T164 T163 arg1Of factor,transcription
R107 T164 T165 arg1Of factor,for
R108 T166 T167 arg1Of natural,","
R109 T168 T167 arg2Of thymus-derived,","
R110 T170 T166 arg1Of nTreg,natural
R111 T170 T168 arg1Of nTreg,thymus-derived
R112 T170 T169 arg2Of nTreg,(
R113 T170 T172 arg1Of nTreg,and
R114 T171 T169 arg3Of ),(
R115 T172 T165 arg2Of and,for
R116 T176 T175 arg2Of iTreg,(
R117 T177 T175 arg3Of ),(
R118 T178 T172 arg2Of commitment,and
R119 T178 T173 arg1Of commitment,inducible
R120 T178 T174 arg1Of commitment,Treg
R121 T178 T175 arg1Of commitment,(
R122 T183 T182 arg1Of mechanisms,the
R123 T183 T184 arg1Of mechanisms,regulating
R124 T183 T187 arg1Of mechanisms,are
R125 T183 T190 arg1Of mechanisms,unknown
R126 T186 T184 arg2Of expression,regulating
R127 T186 T185 arg1Of expression,its
R128 T187 T179 arg2Of are,;
R129 T187 T180 arg1Of are,however
R130 T187 T181 arg1Of are,","
R131 T187 T189 arg1Of are,yet
R132 T189 T188 arg1Of yet,as
R133 T190 T187 arg2Of unknown,are
R134 T191 T192 arg1Of We,describe
R135 T194 T192 arg2Of mechanism,describe
R136 T194 T193 arg1Of mechanism,a
R137 T194 T195 arg1Of mechanism,controlling
R138 T197 T195 arg2Of polarization,controlling
R139 T197 T196 arg1Of polarization,iTreg
R140 T197 T198 arg1Of polarization,","
R141 T197 T199 arg1Of polarization,which
R142 T197 T200 arg1Of polarization,is
R143 T197 T201 arg2Of polarization,overruled
R144 T201 T200 arg2Of overruled,is
R145 T206 T201 arg1Of pathway,overruled
R146 T206 T202 arg2Of pathway,by
R147 T206 T203 arg1Of pathway,the
R148 T206 T204 arg1Of pathway,Th2
R149 T206 T205 arg1Of pathway,differentiation
R150 T207 T208 arg1Of We,demonstrated
R151 T210 T211 arg1Of interleukin,4
R152 T210 T212 arg1Of interleukin,(
R153 T210 T215 arg1Of interleukin,present
R154 T210 T223 arg1Of interleukin,inhibits
R155 T213 T212 arg2Of IL-4,(
R156 T214 T212 arg3Of ),(
R157 T215 T216 arg1Of present,at
R158 T218 T216 arg2Of time,at
R159 T218 T217 arg1Of time,the
R160 T218 T219 arg1Of time,of
R161 T222 T219 arg2Of priming,of
R162 T222 T220 arg1Of priming,T
R163 T222 T221 arg1Of priming,cell
R164 T223 T208 arg2Of inhibits,demonstrated
R165 T223 T209 arg1Of inhibits,that
R166 T224 T223 arg2Of FOXP3,inhibits
R167 T227 T225 arg1Of mechanism,This
R168 T227 T226 arg1Of mechanism,inhibitory
R169 T227 T228 arg1Of mechanism,was
R170 T227 T230 arg2Of mechanism,confirmed
R171 T230 T228 arg2Of confirmed,was
R172 T230 T229 arg1Of confirmed,also
R173 T230 T231 arg1Of confirmed,in
R174 T230 T235 arg1Of confirmed,in
R175 T231 T234 arg1Of in,and
R176 T233 T231 arg2Of cells,in
R177 T233 T232 arg1Of cells,Th2
R178 T235 T234 arg2Of in,and
R179 T237 T235 arg2Of cells,in
R180 T237 T236 arg1Of cells,T
R181 T237 T238 arg1Of cells,of
R182 T240 T238 arg2Of mice,of
R183 T240 T239 arg1Of mice,transgenic
R184 T240 T241 arg1Of mice,overexpressing
R185 T240 T246 arg1Of mice,","
R186 T240 T247 arg1Of mice,which
R187 T240 T248 arg1Of mice,are
R188 T240 T249 arg2Of mice,shown
R189 T240 T251 arg1Of mice,be
R190 T240 T252 arg1Of mice,deficient
R191 T241 T243 arg1Of overexpressing,in
R192 T242 T241 arg2Of GATA-3,overexpressing
R193 T245 T243 arg2Of cells,in
R194 T245 T244 arg1Of cells,T
R195 T249 T248 arg2Of shown,are
R196 T251 T249 arg3Of be,shown
R197 T251 T250 arg1Of be,to
R198 T252 T251 arg2Of deficient,be
R199 T252 T253 arg1Of deficient,in
R200 T254 T253 arg2Of transforming,in
R201 T258 T257 arg2Of TGF,(
R202 T259 T257 arg3Of ),(
R203 T262 T254 arg2Of induction,transforming
R204 T262 T255 arg1Of induction,growth
R205 T262 T256 arg1Of induction,factor
R206 T262 T257 arg1Of induction,(
R207 T262 T260 arg1Of induction,-β–mediated
R208 T262 T261 arg1Of induction,FOXP3
R209 T264 T263 arg1Of inhibition,This
R210 T264 T265 arg1Of inhibition,is
R211 T264 T266 arg2Of inhibition,mediated
R212 T266 T265 arg2Of mediated,is
R213 T269 T266 arg1Of binding,mediated
R214 T269 T267 arg2Of binding,by
R215 T269 T268 arg1Of binding,direct
R216 T269 T270 arg1Of binding,of
R217 T269 T272 arg1Of binding,to
R218 T269 T276 arg1Of binding,","
R219 T269 T277 arg1Of binding,which
R220 T269 T278 arg1Of binding,represses
R221 T271 T270 arg2Of GATA3,of
R222 T275 T272 arg2Of promoter,to
R223 T275 T273 arg1Of promoter,the
R224 T275 T274 arg1Of promoter,FOXP3
R225 T281 T278 arg2Of process,represses
R226 T281 T279 arg1Of process,its
R227 T281 T280 arg1Of process,transactivation
R228 T285 T284 arg1Of study,this
R229 T285 T286 arg1Of study,provides
R230 T286 T282 arg1Of provides,Therefore
R231 T286 T283 arg1Of provides,","
R232 T289 T286 arg2Of understanding,provides
R233 T289 T287 arg1Of understanding,a
R234 T289 T288 arg1Of understanding,new
R235 T289 T290 arg1Of understanding,of
R236 T289 T293 arg1Of understanding,","
R237 T289 T294 arg2Of understanding,controlled
R238 T292 T290 arg2Of development,of
R239 T292 T291 arg1Of development,tolerance
R240 T300 T294 arg1Of response,controlled
R241 T300 T295 arg2Of response,by
R242 T300 T296 arg1Of response,a
R243 T300 T297 arg1Of response,type
R244 T300 T298 arg1Of response,2
R245 T300 T299 arg1Of response,immune
R246 T302 T301 arg1Of treatment,IL-4
R247 T302 T303 arg1Of treatment,in
R248 T302 T305 arg1Of treatment,reduces
R249 T302 T310 arg1Of treatment,highlighting
R250 T304 T303 arg2Of mice,in
R251 T305 T309 arg1Of reduces,","
R252 T305 T310 modOf reduces,highlighting
R253 T308 T305 arg2Of frequency,reduces
R254 T308 T306 arg1Of frequency,iTreg
R255 T308 T307 arg1Of frequency,cell
R256 T313 T312 arg1Of approaches,therapeutic
R257 T313 T314 arg1Of approaches,that
R258 T313 T315 arg1Of approaches,target
R259 T313 T319 arg1Of approaches,might
R260 T313 T320 arg1Of approaches,provide
R261 T316 T317 arg1Of IL-4,or
R262 T317 T315 arg2Of or,target
R263 T318 T317 arg2Of GATA3,or
R264 T320 T310 arg2Of provide,highlighting
R265 T320 T311 arg1Of provide,that
R266 T320 T319 arg2Of provide,might
R267 T320 T328 arg1Of provide,in
R268 T323 T320 arg2Of strategies,provide
R269 T323 T321 arg1Of strategies,new
R270 T323 T322 arg1Of strategies,preventive
R271 T323 T324 arg1Of strategies,facilitating
R272 T326 T324 arg2Of induction,facilitating
R273 T326 T325 arg1Of induction,tolerance
R274 T328 T327 arg1Of in,particularly
R275 T330 T328 arg2Of diseases,in
R276 T330 T329 arg1Of diseases,Th2-mediated
R277 T330 T331 arg1Of diseases,","
R278 T330 T333 arg1Of diseases,as
R279 T333 T332 arg1Of as,such
R280 T334 T333 arg2Of allergy,as

bionlp-st-ge-2016-coref

Id Subject Object Predicate Lexical cue
T335 382-385 Anaphor denotes its
T336 229-234 Antecedent denotes FOXP3
T337 846-861 Anaphor denotes This inhibition
T338 772-781 Antecedent denotes deficient
R634 T335 T336 boundBy its,FOXP3
R635 T337 T338 boundBy This inhibition,deficient

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T376 0-13 NNP denotes Transcription
T377 14-21 NNS denotes factors
T378 22-25 VBP denotes act
T379 26-28 IN denotes in
T380 29-36 NN denotes concert
T381 37-39 TO denotes to
T382 40-46 VB denotes induce
T383 47-54 NN denotes lineage
T384 55-65 NN denotes commitment
T385 66-73 IN denotes towards
T386 74-77 NNP denotes Th1
T387 77-78 , denotes ,
T388 79-82 NNP denotes Th2
T389 82-83 , denotes ,
T390 84-86 CC denotes or
T391 87-88 NNP denotes T
T392 89-99 JJ denotes regulatory
T393 100-101 -LRB- denotes (
T394 101-105 NNP denotes Treg
T395 105-106 -RRB- denotes )
T396 107-112 NNS denotes cells
T397 112-113 , denotes ,
T398 114-117 CC denotes and
T399 118-123 PRP$ denotes their
T400 124-142 JJ denotes counter-regulatory
T401 143-153 NNS denotes mechanisms
T402 154-158 VBD denotes were
T403 159-164 VBN denotes shown
T404 165-167 TO denotes to
T405 168-170 VB denotes be
T406 171-179 JJ denotes critical
T407 180-183 IN denotes for
T408 184-196 NN denotes polarization
T409 197-204 IN denotes between
T410 205-208 CD denotes Th1
T411 209-212 CC denotes and
T412 213-216 CD denotes Th2
T413 217-227 NNS denotes phenotypes
T414 227-228 . denotes .
T415 229-234 CD denotes FOXP3
T416 235-237 VBZ denotes is
T417 238-240 DT denotes an
T418 241-250 JJ denotes essential
T419 251-264 NN denotes transcription
T420 265-271 NN denotes factor
T421 272-275 IN denotes for
T422 276-283 JJ denotes natural
T423 283-284 , denotes ,
T424 285-299 JJ denotes thymus-derived
T425 300-301 -LRB- denotes (
T426 301-306 NNP denotes nTreg
T427 306-307 -RRB- denotes )
T428 308-311 CC denotes and
T429 312-321 JJ denotes inducible
T430 322-326 NNP denotes Treg
T431 327-328 -LRB- denotes (
T432 328-333 NNP denotes iTreg
T433 333-334 -RRB- denotes )
T434 335-345 NN denotes commitment
T435 345-346 : denotes ;
T436 347-354 RB denotes however
T437 354-355 , denotes ,
T438 356-359 DT denotes the
T439 360-370 NNS denotes mechanisms
T440 371-381 VBG denotes regulating
T441 382-385 PRP$ denotes its
T442 386-396 NN denotes expression
T443 397-400 VBP denotes are
T444 401-403 RB denotes as
T445 404-407 RB denotes yet
T446 408-415 JJ denotes unknown
T447 415-416 . denotes .
T448 417-419 PRP denotes We
T449 420-428 VBP denotes describe
T450 429-430 DT denotes a
T451 431-440 NN denotes mechanism
T452 441-452 VBG denotes controlling
T453 453-458 NNP denotes iTreg
T454 459-471 NN denotes polarization
T455 471-472 , denotes ,
T456 473-478 WDT denotes which
T457 479-481 VBZ denotes is
T458 482-491 VBN denotes overruled
T459 492-494 IN denotes by
T460 495-498 DT denotes the
T461 499-502 JJ denotes Th2
T462 503-518 NN denotes differentiation
T463 519-526 NN denotes pathway
T464 526-527 . denotes .
T465 528-530 PRP denotes We
T466 531-543 VBD denotes demonstrated
T467 544-548 IN denotes that
T468 549-560 NN denotes interleukin
T469 561-562 CD denotes 4
T470 563-564 -LRB- denotes (
T471 564-568 NN denotes IL-4
T472 568-569 -RRB- denotes )
T473 570-577 NN denotes present
T474 578-580 IN denotes at
T475 581-584 DT denotes the
T476 585-589 NN denotes time
T477 590-592 IN denotes of
T478 593-594 NNP denotes T
T479 595-599 NN denotes cell
T480 600-607 VBG denotes priming
T481 608-616 NNS denotes inhibits
T482 617-622 NNP denotes FOXP3
T483 622-623 . denotes .
T484 624-628 DT denotes This
T485 629-639 JJ denotes inhibitory
T486 640-649 NN denotes mechanism
T487 650-653 VBD denotes was
T488 654-658 RB denotes also
T489 659-668 VBN denotes confirmed
T490 669-671 IN denotes in
T491 672-675 JJ denotes Th2
T492 676-681 NNS denotes cells
T493 682-685 CC denotes and
T494 686-688 IN denotes in
T495 689-690 NNP denotes T
T496 691-696 NNS denotes cells
T497 697-699 IN denotes of
T498 700-710 JJ denotes transgenic
T499 711-715 NNS denotes mice
T500 716-730 VBG denotes overexpressing
T501 731-737 NN denotes GATA-3
T502 738-740 IN denotes in
T503 741-742 NNP denotes T
T504 743-748 NNS denotes cells
T505 748-749 , denotes ,
T506 750-755 WDT denotes which
T507 756-759 VBP denotes are
T508 760-765 VBN denotes shown
T509 766-768 TO denotes to
T510 769-771 VB denotes be
T511 772-781 JJ denotes deficient
T512 782-784 IN denotes in
T513 785-797 VBG denotes transforming
T514 798-804 NN denotes growth
T515 805-811 NN denotes factor
T516 812-813 -LRB- denotes (
T517 813-816 NNP denotes TGF
T518 816-817 -RRB- denotes )
T519 817-818 : denotes -
T520 818-819 NN denotes β
T521 820-828 VBD denotes mediated
T522 829-834 CD denotes FOXP3
T523 835-844 NN denotes induction
T524 844-845 . denotes .
T525 846-850 DT denotes This
T526 851-861 NN denotes inhibition
T527 862-864 VBZ denotes is
T528 865-873 VBN denotes mediated
T529 874-876 IN denotes by
T530 877-883 JJ denotes direct
T531 884-891 JJ denotes binding
T532 892-894 IN denotes of
T533 895-900 CD denotes GATA3
T534 901-903 TO denotes to
T535 904-907 DT denotes the
T536 908-913 CD denotes FOXP3
T537 914-922 NN denotes promoter
T538 922-923 , denotes ,
T539 924-929 WDT denotes which
T540 930-939 VBZ denotes represses
T541 940-943 PRP$ denotes its
T542 944-959 NN denotes transactivation
T543 960-967 NN denotes process
T544 967-968 . denotes .
T545 969-978 RB denotes Therefore
T546 978-979 , denotes ,
T547 980-984 DT denotes this
T548 985-990 NN denotes study
T549 991-999 VBZ denotes provides
T550 1000-1001 DT denotes a
T551 1002-1005 JJ denotes new
T552 1006-1019 NN denotes understanding
T553 1020-1022 IN denotes of
T554 1023-1032 NN denotes tolerance
T555 1033-1044 NN denotes development
T556 1044-1045 , denotes ,
T557 1046-1056 VBN denotes controlled
T558 1057-1059 IN denotes by
T559 1060-1061 DT denotes a
T560 1062-1066 NN denotes type
T561 1067-1068 CD denotes 2
T562 1069-1075 JJ denotes immune
T563 1076-1084 NN denotes response
T564 1084-1085 . denotes .
T565 1086-1090 NN denotes IL-4
T566 1091-1100 NN denotes treatment
T567 1101-1103 IN denotes in
T568 1104-1108 NNS denotes mice
T569 1109-1116 VBZ denotes reduces
T570 1117-1122 NNP denotes iTreg
T571 1123-1127 NN denotes cell
T572 1128-1137 NN denotes frequency
T573 1137-1138 , denotes ,
T574 1139-1151 VBG denotes highlighting
T575 1152-1156 IN denotes that
T576 1157-1168 JJ denotes therapeutic
T577 1169-1179 NNS denotes approaches
T578 1180-1184 WDT denotes that
T579 1185-1191 VBP denotes target
T580 1192-1196 NN denotes IL-4
T581 1197-1199 CC denotes or
T582 1200-1205 NN denotes GATA3
T583 1206-1211 MD denotes might
T584 1212-1219 VB denotes provide
T585 1220-1223 JJ denotes new
T586 1224-1234 JJ denotes preventive
T587 1235-1245 NNS denotes strategies
T588 1246-1258 VBG denotes facilitating
T589 1259-1268 NN denotes tolerance
T590 1269-1278 NN denotes induction
T591 1279-1291 RB denotes particularly
T592 1292-1294 IN denotes in
T593 1295-1307 JJ denotes Th2-mediated
T594 1308-1316 NNS denotes diseases
T595 1316-1317 , denotes ,
T596 1318-1322 JJ denotes such
T597 1323-1325 IN denotes as
T598 1326-1333 NN denotes allergy
T599 1333-1334 . denotes .
R296 T376 T377 compound Transcription,factors
R299 T379 T378 prep in,act
R300 T380 T379 pobj concert,in
R301 T381 T382 aux to,induce
R302 T382 T378 advcl induce,act
R303 T383 T384 compound lineage,commitment
R304 T384 T382 dobj commitment,induce
R305 T385 T384 prep towards,commitment
R306 T386 T385 pobj Th1,towards
R307 T387 T386 punct ",",Th1
R308 T388 T386 conj Th2,Th1
R309 T389 T388 punct ",",Th2
R310 T390 T388 cc or,Th2
R311 T391 T388 conj T,Th2
R312 T392 T396 amod regulatory,cells
R313 T393 T394 punct (,Treg
R314 T394 T392 appos Treg,regulatory
R315 T395 T394 punct ),Treg
R316 T396 T385 pobj cells,towards
R317 T397 T378 punct ",",act
R318 T398 T378 cc and,act
R319 T399 T401 poss their,mechanisms
R320 T400 T401 amod counter-regulatory,mechanisms
R321 T401 T403 nsubjpass mechanisms,shown
R378 T458 T454 relcl overruled,polarization
R379 T459 T458 agent by,overruled
R380 T460 T463 det the,pathway
R381 T461 T463 amod Th2,pathway
R382 T462 T463 compound differentiation,pathway
R383 T463 T459 pobj pathway,by
R384 T464 T449 punct .,describe
R385 T465 T466 nsubj We,demonstrated
R386 T466 T466 ROOT demonstrated,demonstrated
R387 T467 T481 mark that,inhibits
R388 T468 T481 nsubj interleukin,inhibits
R389 T469 T468 nummod 4,interleukin
R390 T470 T471 punct (,IL-4
R391 T471 T468 appos IL-4,interleukin
R392 T472 T471 punct ),IL-4
R393 T473 T468 amod present,interleukin
R394 T474 T468 prep at,interleukin
R395 T475 T476 det the,time
R396 T476 T474 pobj time,at
R397 T477 T476 prep of,time
R398 T478 T479 compound T,cell
R399 T479 T480 compound cell,priming
R400 T480 T481 nsubj priming,inhibits
R401 T481 T466 ccomp inhibits,demonstrated
R402 T482 T481 dobj FOXP3,inhibits
R403 T483 T466 punct .,demonstrated
R404 T484 T486 det This,mechanism
R405 T485 T486 amod inhibitory,mechanism
R406 T486 T489 nsubjpass mechanism,confirmed
R407 T487 T489 auxpass was,confirmed
R408 T488 T489 advmod also,confirmed
R409 T489 T489 ROOT confirmed,confirmed
R410 T490 T489 prep in,confirmed
R411 T491 T492 amod Th2,cells
R412 T492 T490 pobj cells,in
R413 T493 T490 cc and,in
R414 T494 T490 conj in,in
R415 T495 T496 compound T,cells
R416 T496 T494 pobj cells,in
R417 T497 T496 prep of,cells
R418 T498 T499 amod transgenic,mice
R419 T499 T497 pobj mice,of
R420 T500 T489 advcl overexpressing,confirmed
R421 T501 T500 dobj GATA-3,overexpressing
R422 T502 T500 prep in,overexpressing
R423 T503 T504 compound T,cells
R424 T504 T502 pobj cells,in
R425 T505 T489 punct ",",confirmed
R426 T506 T508 nsubjpass which,shown
R427 T507 T508 auxpass are,shown
R428 T508 T489 advcl shown,confirmed
R429 T509 T510 aux to,be
R430 T510 T508 xcomp be,shown
R431 T511 T510 acomp deficient,be
R432 T512 T511 prep in,deficient
R433 T513 T512 pcomp transforming,in
R434 T514 T515 compound growth,factor
R435 T515 T513 dobj factor,transforming
R436 T516 T517 punct (,TGF
R437 T517 T515 appos TGF,factor
R438 T518 T517 punct ),TGF
R439 T519 T515 punct -,factor
R440 T520 T515 appos β,factor
R441 T521 T489 conj mediated,confirmed
R442 T522 T523 nummod FOXP3,induction
R443 T523 T521 dobj induction,mediated
R444 T524 T489 punct .,confirmed
R445 T525 T526 det This,inhibition
R446 T526 T528 nsubjpass inhibition,mediated
R447 T527 T528 auxpass is,mediated
R448 T528 T528 ROOT mediated,mediated
R449 T529 T528 agent by,mediated
R450 T530 T531 amod direct,binding
R451 T531 T529 pobj binding,by
R452 T532 T531 prep of,binding
R453 T533 T532 pobj GATA3,of
R454 T534 T528 prep to,mediated
R455 T535 T537 det the,promoter
R456 T536 T537 nummod FOXP3,promoter
R457 T537 T534 pobj promoter,to
R458 T538 T537 punct ",",promoter
R459 T539 T540 nsubj which,represses
R460 T540 T537 relcl represses,promoter
R461 T541 T543 poss its,process
R462 T542 T543 compound transactivation,process
R463 T543 T540 dobj process,represses
R464 T544 T528 punct .,mediated
R465 T545 T549 advmod Therefore,provides
R466 T546 T549 punct ",",provides
R467 T547 T548 det this,study
R468 T548 T549 nsubj study,provides
R469 T549 T549 ROOT provides,provides
R470 T550 T552 det a,understanding
R471 T551 T552 amod new,understanding
R472 T552 T549 dobj understanding,provides
R473 T553 T552 prep of,understanding
R474 T554 T555 compound tolerance,development
R475 T555 T553 pobj development,of
R476 T556 T552 punct ",",understanding
R477 T557 T552 acl controlled,understanding
R478 T558 T557 agent by,controlled
R479 T559 T563 det a,response
R480 T560 T563 nmod type,response
R481 T561 T560 nummod 2,type
R482 T562 T563 amod immune,response
R483 T563 T558 pobj response,by
R484 T564 T549 punct .,provides
R485 T565 T566 compound IL-4,treatment
R486 T566 T569 nsubj treatment,reduces
R487 T567 T566 prep in,treatment
R488 T568 T567 pobj mice,in
R489 T569 T569 ROOT reduces,reduces
R490 T570 T572 compound iTreg,frequency
R491 T571 T572 compound cell,frequency
R492 T572 T569 dobj frequency,reduces
R493 T573 T569 punct ",",reduces
R494 T574 T569 advcl highlighting,reduces
R495 T575 T584 mark that,provide
R496 T576 T577 amod therapeutic,approaches
R497 T577 T584 nsubj approaches,provide
R498 T578 T579 nsubj that,target
R499 T579 T577 relcl target,approaches
R500 T580 T579 dobj IL-4,target
R501 T581 T580 cc or,IL-4
R502 T582 T580 conj GATA3,IL-4
R503 T583 T584 aux might,provide
R504 T584 T574 ccomp provide,highlighting
R505 T585 T587 amod new,strategies
R506 T586 T587 amod preventive,strategies
R507 T587 T584 dobj strategies,provide
R508 T588 T584 advcl facilitating,provide
R509 T589 T590 compound tolerance,induction
R510 T590 T588 dobj induction,facilitating
R511 T591 T592 advmod particularly,in
R512 T592 T590 prep in,induction
R513 T593 T594 amod Th2-mediated,diseases
R514 T594 T592 pobj diseases,in
R515 T595 T594 punct ",",diseases
R516 T596 T597 amod such,as
R517 T597 T594 prep as,diseases
R518 T598 T597 pobj allergy,as
R519 T599 T569 punct .,reduces
R322 T402 T403 auxpass were,shown
R323 T403 T378 conj shown,act
R324 T404 T405 aux to,be
R325 T405 T403 xcomp be,shown
R326 T406 T405 acomp critical,be
R327 T407 T406 prep for,critical
R328 T408 T407 pobj polarization,for
R329 T409 T408 prep between,polarization
R330 T410 T413 nummod Th1,phenotypes
R331 T411 T410 cc and,Th1
R332 T412 T410 conj Th2,Th1
R333 T413 T409 pobj phenotypes,between
R334 T414 T403 punct .,shown
R335 T415 T416 nsubj FOXP3,is
R336 T416 T443 ccomp is,are
R337 T417 T420 det an,factor
R338 T418 T420 amod essential,factor
R339 T419 T420 compound transcription,factor
R340 T420 T416 attr factor,is
R341 T421 T420 prep for,factor
R342 T422 T430 amod natural,Treg
R343 T423 T422 punct ",",natural
R344 T424 T422 conj thymus-derived,natural
R345 T425 T426 punct (,nTreg
R346 T426 T424 appos nTreg,thymus-derived
R347 T427 T426 punct ),nTreg
R348 T428 T424 cc and,thymus-derived
R349 T429 T424 conj inducible,thymus-derived
R350 T430 T421 pobj Treg,for
R351 T431 T432 punct (,iTreg
R352 T432 T430 appos iTreg,Treg
R353 T433 T430 punct ),Treg
R354 T434 T420 conj commitment,factor
R355 T435 T443 punct ;,are
R356 T436 T443 advmod however,are
R357 T437 T443 punct ",",are
R358 T438 T439 det the,mechanisms
R359 T439 T443 nsubj mechanisms,are
R360 T440 T439 acl regulating,mechanisms
R361 T441 T442 poss its,expression
R362 T442 T440 dobj expression,regulating
R363 T443 T443 ROOT are,are
R364 T444 T446 advmod as,unknown
R365 T445 T446 advmod yet,unknown
R366 T446 T443 acomp unknown,are
R367 T447 T443 punct .,are
R368 T448 T449 nsubj We,describe
R369 T449 T449 ROOT describe,describe
R370 T450 T451 det a,mechanism
R371 T451 T454 amod mechanism,polarization
R372 T452 T454 amod controlling,polarization
R373 T453 T454 compound iTreg,polarization
R374 T454 T449 dobj polarization,describe
R375 T455 T454 punct ",",polarization
R376 T456 T458 nsubjpass which,overruled
R377 T457 T458 auxpass is,overruled

UBERON-AE

Id Subject Object Predicate Lexical cue
T57 285-291 http://purl.obolibrary.org/obo/UBERON_0002370 denotes thymus

GO-BP

Id Subject Object Predicate Lexical cue
T68 0-13 http://purl.obolibrary.org/obo/GO_0006351 denotes Transcription
T69 251-264 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T70 798-804 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T71 944-959 http://purl.obolibrary.org/obo/GO_2000144 denotes transactivation
T72 1033-1044 http://purl.obolibrary.org/obo/GO_0032502 denotes development
T73 1069-1084 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T74 1076-1090 http://purl.obolibrary.org/obo/GO_0071353 denotes response. IL-4
T75 1076-1090 http://purl.obolibrary.org/obo/GO_0070670 denotes response. IL-4
T76 1259-1278 http://purl.obolibrary.org/obo/GO_0002507 denotes tolerance induction

GO-MF

Id Subject Object Predicate Lexical cue
T631 561-566 http://purl.obolibrary.org/obo/GO_0005136 denotes 4 (IL
T632 1086-1090 http://purl.obolibrary.org/obo/GO_0005136 denotes IL-4
T633 1192-1196 http://purl.obolibrary.org/obo/GO_0005136 denotes IL-4
T634 884-891 http://purl.obolibrary.org/obo/GO_0005488 denotes binding

GO-CC

Id Subject Object Predicate Lexical cue
T635 107-112 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T636 676-681 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T637 691-696 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T638 743-748 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T639 1123-1127 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

sentences

Id Subject Object Predicate Lexical cue
T59 0-228 Sentence denotes Transcription factors act in concert to induce lineage commitment towards Th1, Th2, or T regulatory (Treg) cells, and their counter-regulatory mechanisms were shown to be critical for polarization between Th1 and Th2 phenotypes.
T60 229-416 Sentence denotes FOXP3 is an essential transcription factor for natural, thymus-derived (nTreg) and inducible Treg (iTreg) commitment; however, the mechanisms regulating its expression are as yet unknown.
T61 417-527 Sentence denotes We describe a mechanism controlling iTreg polarization, which is overruled by the Th2 differentiation pathway.
T62 528-623 Sentence denotes We demonstrated that interleukin 4 (IL-4) present at the time of T cell priming inhibits FOXP3.
T63 624-845 Sentence denotes This inhibitory mechanism was also confirmed in Th2 cells and in T cells of transgenic mice overexpressing GATA-3 in T cells, which are shown to be deficient in transforming growth factor (TGF)-β–mediated FOXP3 induction.
T64 846-968 Sentence denotes This inhibition is mediated by direct binding of GATA3 to the FOXP3 promoter, which represses its transactivation process.
T65 969-1085 Sentence denotes Therefore, this study provides a new understanding of tolerance development, controlled by a type 2 immune response.
T66 1086-1334 Sentence denotes IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy.
T3 0-228 Sentence denotes Transcription factors act in concert to induce lineage commitment towards Th1, Th2, or T regulatory (Treg) cells, and their counter-regulatory mechanisms were shown to be critical for polarization between Th1 and Th2 phenotypes.
T4 229-416 Sentence denotes FOXP3 is an essential transcription factor for natural, thymus-derived (nTreg) and inducible Treg (iTreg) commitment; however, the mechanisms regulating its expression are as yet unknown.
T5 417-527 Sentence denotes We describe a mechanism controlling iTreg polarization, which is overruled by the Th2 differentiation pathway.
T6 528-623 Sentence denotes We demonstrated that interleukin 4 (IL-4) present at the time of T cell priming inhibits FOXP3.
T7 624-845 Sentence denotes This inhibitory mechanism was also confirmed in Th2 cells and in T cells of transgenic mice overexpressing GATA-3 in T cells, which are shown to be deficient in transforming growth factor (TGF)-β–mediated FOXP3 induction.
T8 846-968 Sentence denotes This inhibition is mediated by direct binding of GATA3 to the FOXP3 promoter, which represses its transactivation process.
T9 969-1085 Sentence denotes Therefore, this study provides a new understanding of tolerance development, controlled by a type 2 immune response.
T10 1086-1334 Sentence denotes IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy.

ICD10

Id Subject Object Predicate Lexical cue
T630 1326-1333 http://purl.bioontology.org/ontology/ICD10/T78.4 denotes allergy

events-check-again

Id Subject Object Predicate Lexical cue Speculation
T768 785-819 Protein denotes transforming growth factor (TGF)-β
T769 820-828 Positive_regulation denotes mediated
T770 829-834 Protein denotes FOXP3
T771 835-844 Positive_regulation denotes induction
T772 865-873 Positive_regulation denotes mediated
T773 884-891 Binding denotes binding
T774 895-900 Protein denotes GATA3
T775 908-913 Protein denotes FOXP3
T776 914-922 Entity denotes promoter
T777 1086-1090 Protein denotes IL-4
T778 1185-1191 Regulation denotes target
T779 1185-1191 Regulation denotes target
T780 1192-1196 Protein denotes IL-4
T781 1200-1205 Protein denotes GATA3
T758 229-234 Protein denotes FOXP3
T759 371-381 Regulation denotes regulating true
T760 386-396 Gene_expression denotes expression
T761 549-562 Protein denotes interleukin 4
T762 564-568 Protein denotes IL-4
T763 608-616 Negative_regulation denotes inhibits
T764 617-622 Protein denotes FOXP3
T765 716-730 Gene_expression denotes overexpressing
T766 731-737 Protein denotes GATA-3
T767 772-781 Negative_regulation denotes deficient
R607 T780 T778 themeOf IL-4,target
R608 T781 T779 themeOf GATA3,target
R658 T760 T759 themeOf expression,regulating
R660 T762 T761 equivalentTo IL-4,interleukin 4
R599 T768 T769 causeOf transforming growth factor (TGF)-β,mediated
R600 T769 T767 themeOf mediated,deficient
R601 T770 T771 themeOf FOXP3,induction
R602 T771 T769 themeOf induction,mediated
R603 T773 T772 causeOf binding,mediated
R604 T774 T773 themeOf GATA3,binding
R605 T776 T773 themeOf promoter,binding
R606 T776 T775 partOf promoter,FOXP3
R657 T758 T760 themeOf FOXP3,expression
R659 T761 T763 causeOf interleukin 4,inhibits
R661 T764 T763 themeOf FOXP3,inhibits
R662 T766 T765 themeOf GATA-3,overexpressing
R663 T767 T772 themeOf deficient,mediated

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T647 205-208 Protein denotes Th1
T648 213-227 Protein denotes Th2 phenotypes
T649 229-234 Protein denotes FOXP3
T650 386-396 Gene_expression denotes expression
T651 371-381 Regulation denotes regulating
T652 549-562 Protein denotes interleukin 4
T653 564-568 Protein denotes IL-4
T654 617-622 Protein denotes FOXP3
T655 608-616 Negative_regulation denotes inhibits
T656 608-616 Negative_regulation denotes inhibits
T657 731-737 Protein denotes GATA-3
T658 829-834 Protein denotes FOXP3
T659 716-730 Gene_expression denotes overexpressing
T660 835-844 Positive_regulation denotes induction
T661 772-781 Negative_regulation denotes deficient
T662 895-900 Protein denotes GATA3
T663 908-922 Protein denotes FOXP3 promoter
T664 884-891 Binding denotes binding
T665 884-891 Binding denotes binding
T666 1086-1090 Protein denotes IL-4
T667 1185-1196 Protein denotes target IL-4
T668 1200-1205 Protein denotes GATA3
R555 T662 T665 themeOf GATA3,binding
R556 T663 T665 themeOf FOXP3 promoter,binding
R545 T649 T650 themeOf FOXP3,expression
R546 T650 T651 themeOf expression,regulating
R547 T652 T655 causeOf interleukin 4,inhibits
R548 T653 T656 causeOf IL-4,inhibits
R549 T654 T655 themeOf FOXP3,inhibits
R550 T654 T656 themeOf FOXP3,inhibits
R551 T657 T659 themeOf GATA-3,overexpressing
R552 T658 T660 themeOf FOXP3,induction
R553 T660 T661 themeOf induction,deficient
R554 T662 T664 themeOf GATA3,binding

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue Speculation
T102 549-562 Protein denotes interleukin 4
T103 564-568 Protein denotes IL-4
T104 617-622 Protein denotes FOXP3
T105 731-737 Protein denotes GATA-3
T106 785-819 Protein denotes transforming growth factor (TGF)-β
T78 835-844 Positive_regulation denotes induction
T79 865-873 Positive_regulation denotes mediated
T80 884-891 Binding denotes binding
T81 1185-1191 Regulation denotes target
T82 1185-1191 Regulation denotes target
T85 371-381 Regulation denotes regulating true
T86 386-396 Gene_expression denotes expression
T87 608-616 Negative_regulation denotes inhibits
T88 716-730 Gene_expression denotes overexpressing
T89 772-781 Negative_regulation denotes deficient
T90 820-828 Positive_regulation denotes mediated
T92 829-834 Protein denotes FOXP3
T93 895-900 Protein denotes GATA3
T94 908-913 Protein denotes FOXP3
T95 1086-1090 Protein denotes IL-4
T96 1192-1196 Protein denotes IL-4
T97 1200-1205 Protein denotes GATA3
T100 914-922 Entity denotes promoter
T101 229-234 Protein denotes FOXP3
R622 T86 T85 themeOf expression,regulating
R623 T89 T79 themeOf deficient,mediated
R624 T90 T89 themeOf mediated,deficient
R625 T92 T78 themeOf FOXP3,induction
R626 T93 T80 themeOf GATA3,binding
R627 T96 T81 themeOf IL-4,target
R628 T97 T82 themeOf GATA3,target
R631 T100 T80 themeOf promoter,binding
R632 T100 T94 partOf promoter,FOXP3
R633 T101 T86 themeOf FOXP3,expression
R39 T102 T87 causeOf interleukin 4,inhibits
R40 T103 T102 equivalentTo IL-4,interleukin 4
R41 T104 T87 themeOf FOXP3,inhibits
R42 T105 T88 themeOf GATA-3,overexpressing
R43 T106 T90 causeOf transforming growth factor (TGF)-β,mediated
R618 T78 T90 themeOf induction,mediated
R619 T80 T79 causeOf binding,mediated

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T341 229-234 Q9BZS1 denotes FOXP3
T342 549-562 P05112 denotes interleukin 4
T343 564-568 P05112 denotes IL-4
T344 617-622 Q9BZS1 denotes FOXP3
T345 731-737 P23771 denotes GATA-3
T346 829-834 Q9BZS1 denotes FOXP3
T347 895-900 P23771 denotes GATA3
T348 908-913 Q9BZS1 denotes FOXP3
T349 1086-1090 P05112 denotes IL-4
T350 1192-1196 P05112 denotes IL-4
T351 1200-1205 P23771 denotes GATA3

test2

Id Subject Object Predicate Lexical cue
T37 229-234 Protein denotes FOXP3
T38 549-562 Protein denotes interleukin 4
T39 564-568 Protein denotes IL-4
T40 608-616 Negative_regulation denotes inhibits
T41 617-622 Protein denotes FOXP3
T42 716-730 Gene_expression denotes overexpressing
T43 731-737 Protein denotes GATA-3
T44 772-781 Negative_regulation denotes deficient
T45 785-819 Protein denotes transforming growth factor (TGF)-β
T46 820-828 Positive_regulation denotes mediated
T47 829-834 Protein denotes FOXP3
T48 835-844 Positive_regulation denotes induction
T49 884-891 Binding denotes binding
T50 895-900 Protein denotes GATA3
T51 908-913 Protein denotes FOXP3
T52 914-922 Entity denotes promoter
T53 1086-1090 Protein denotes IL-4
T54 1185-1191 Binding denotes target
T55 1192-1196 Protein denotes IL-4
T56 1200-1205 Protein denotes GATA3
R27 T38 T40 causeOf interleukin 4,inhibits
R28 T39 T38 equivalentTo IL-4,interleukin 4
R29 T41 T40 themeOf FOXP3,inhibits
R30 T43 T42 themeOf GATA-3,overexpressing
R31 T47 T48 themeOf FOXP3,induction
R32 T48 T46 themeOf induction,mediated
R33 T50 T49 themeOf GATA3,binding
R34 T52 T51 partOf promoter,FOXP3
R35 T52 T49 themeOf promoter,binding
R36 T53 T54 themeOf IL-4,target
R37 T55 T54 themeOf IL-4,target
R38 T56 T54 themeOf GATA3,target